Virtue, Liberty and Independence
RED Tape Act
The bill reduces federal environmental review and CEQ oversight to streamline actions, but shifts responsibility to states/localities, reduces public visibility, and raises the risk of air-quality and health harms for communities.
Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle and Engine Pollution Control Standards; Advanced Clean Cars II; Waiver of Preemption; Notice of Decision".
ORPHAN Cures Act
The bill extends orphan-drug protections to delay price negotiations—trading near-term savings for taxpayers and lower drug costs for many patients in exchange for preserving manufacturer revenues and incentives to develop treatments for rare diseases.
SECURE Data Act
Medicare Advantage Improvement Act of 2026
Diabetes Foot Health Access and Modernization Act of 2026
The bill expands and clarifies coverage for podiatric services and diabetic therapeutic footwear—improving foot‑care access and reducing long‑term complications for many beneficiaries—but it increases Medicare and Medicaid spending and adds administrative burdens that could slow implementation or delay some care.
Sustainable Cardiopulmonary Rehabilitation Services in the Home Act
The bill expands and makes permanent telehealth-based cardiac and pulmonary rehab—improving access and billing clarity for providers and patients—while increasing Medicare costs and creating potential clinical and compliance risks that must be managed.
Community Passport Services Access Act
The bill expands local access to passport services by authorizing qualified public libraries to act as fee‑retaining acceptance sites (helping families and rural communities), but it shifts administrative, security, and oversight burdens onto libraries and the State Department and risks inconsistent fee practices.
Health Tech Investment Act
The bill clarifies and locks in outpatient reimbursement for FDA‑cleared AI/ML and subscription software—improving access and payment predictability for beneficiaries, providers, and vendors—while raising the risk of higher Medicare spending and added administrative/oversight needs unless strong cost verification is enforced.